Press Releases

and/or
567 News Releases found
Media Advisory
Genetic Abnormality May Increase Risk of Blood Disorders

Researchers at Memorial Sloan Kettering Cancer Center have shown for the first time that a tendency to develop some blood disorders may be inherited.
Dr. Tim A. Ahles
NIH Awards $15.9 Million to CCNY and Memorial Sloan Kettering to Create Partnership to Address Cancer Disparities

The National Institutes of Health's National Cancer Institute has awarded The City College of New York and Memorial Sloan Kettering Cancer Center a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach.
A doctor at MSK
Childhood Cancer Survivors Not Following Recommended Breast Cancer Screening Guidelines

The majority of young women at an increased risk of breast cancer due to chest radiation treatment for childhood cancer are not following breast cancer screening recommendations, according to a recently released, detailed assessment appearing in the January 28, 2009, issue of the <I>Journal of the American Medical Association</I>.
Peter B. Bach, MD, MAPP
Media Advisory
Why Cancer Drugs Are So Expensive and Why Medicare Can't Fix the Problem

A new health policy report which will be published in the New England Journal of Medicine suggests that the swift and dramatic rise in cancer-drug spending is due to laws that keep Medicare from managing the use or price of cancer drugs. These laws limit Medicare's actions in cancer far more than they are limited in other areas of healthcare.
Stephen Nimer, MD
Research Shows Cell's Inactive State is Critical for Effectiveness of Cancer Treatment

A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study's findings, researchers identified the genetic pathway used to maintain a cell's quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.
Michelle S. Bradbury
Researchers Create Smaller, Brighter Probe, Tailored for Clinical Molecular Imaging and Tumor Targeting

Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.
Harold Varmus
New Geoffrey Beene Gift to Memorial Sloan Kettering Puts Total Support Over $100 Million

Memorial Sloan Kettering Cancer Center has announced the gift of a membership interest in Geoffrey Beene, LLC, the company that controls the business and fashion empire created by legendary designer Geoffrey Beene.
New Study Examines Effectiveness of Colorectal Cancer Screening Tests and Suggests Screening May Be Stopped at Age 75

New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.
Maureen Killackey, MD
Innovative Relationship Advances Cancer Care in New Jersey

Memorial Sloan Kettering Cancer Center and Summit Medical Group together announce a new collaborative relationship for the care of people with cancer.
James Blake
American Tennis Star James Blake to Launch Cancer Research Fund in His Father's Name at Memorial Sloan Kettering Cancer Center

American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering Cancer Center.